Specific IFRS Standards and Stakeholder Reporting

SECTION B AgriGenetics Co is a large-scale agricultural biotechnology company that cultivates genetically modified crops designed to be drought-resistant. The company is preparing its financial statements for the year ended 31 December 20X5. AgriGenetics has extensive plantations of growing crops. The crops take approximately eight months to reach maturity. At 31 December 20X5, the crops are halfway through their growth cycle. The company has incurred significant costs in planting and maintaining these crops. Management argues that because the crops are not yet mature, they should be held at cost. However, an active market exists for the crops at various stages of growth. During the year, AgriGenetics received a $5 million government grant conditional upon the company maintaining its farming operations in a specific rural, economically deprived region for the next five years. If the company leaves the region before the end of the five years, the grant must be repaid in full. Furthermore, an institutional investor group has written to the Board of Directors expressing concern about the long-term impact of climate change on the company's business model. They have specifically asked how climate-related risks are reflected in the current financial statements, particularly regarding asset valuations. Required: (a) Advise the directors of AgriGenetics on the correct recognition and measurement of the growing crops and the government grant in the financial statements for the year ended 31 December 20X5. (12 marks) (b) Explain to the institutional investor group how climate-related risks should be considered and potentially reflected in the financial statements of AgriGenetics, with specific reference to relevant IFRS Accounting Standards. (13 marks)